476 related articles for article (PubMed ID: 10875679)
1. Rapid determination of rat hepatocyte mRNA induction potential using oligonucleotide probes for CYP1A1, 1A2, 3A and 4A1.
Surry DD; Meneses-Lorente G; Heavens R; Jack A; Evans DC
Xenobiotica; 2000 May; 30(5):441-56. PubMed ID: 10875679
[TBL] [Abstract][Full Text] [Related]
2. Studies on the induction of rat hepatic CYP1A, CYP2B, CYP3A and CYP4A subfamily form mRNAs in vivo and in vitro using precision-cut rat liver slices.
Meredith C; Scott MP; Renwick AB; Price RJ; Lake BG
Xenobiotica; 2003 May; 33(5):511-27. PubMed ID: 12746107
[TBL] [Abstract][Full Text] [Related]
3. High throughput ribonuclease protection assay for the determination of CYP3A mRNA induction in cultured rat hepatocytes.
Surry DD; McAllister G; Meneses-Lorente G; Evans DC
Xenobiotica; 1999 Aug; 29(8):827-38. PubMed ID: 10553723
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the effects of some CYP3A and other enzyme inducers on replicative DNA synthesis and cytochrome P450 isoforms in rat liver.
Lake BG; Renwick AB; Cunninghame ME; Price RJ; Surry D; Evans DC
Toxicology; 1998 Nov; 131(1):9-20. PubMed ID: 9881931
[TBL] [Abstract][Full Text] [Related]
5. CYP isoform induction screening in 96-well plates: use of 7-benzyloxy-4-trifluoromethylcoumarin as a substrate for studies with rat hepatocytes.
Price RJ; Surry D; Renwick AB; Meneses-Lorente G; Lake BG; Evans DC
Xenobiotica; 2000 Aug; 30(8):781-95. PubMed ID: 11037111
[TBL] [Abstract][Full Text] [Related]
6. Insulin differentially affects xenobiotic-enhanced, cytochrome P-450 (CYP)2E1, CYP2B, CYP3A, and CYP4A expression in primary cultured rat hepatocytes.
Woodcroft KJ; Novak RF
J Pharmacol Exp Ther; 1999 May; 289(2):1121-7. PubMed ID: 10215695
[TBL] [Abstract][Full Text] [Related]
7. Effect of troglitazone on cytochrome P450 enzymes in primary cultures of human and rat hepatocytes.
Sahi J; Hamilton G; Sinz M; Barros S; Huang SM; Lesko LJ; LeCluyse EL
Xenobiotica; 2000 Mar; 30(3):273-84. PubMed ID: 10752642
[TBL] [Abstract][Full Text] [Related]
8. Molecular non-genetic biomarkers of effect related to methyl thiophanate cocarcinogenesis: organ- and sex-specific cytochrome P450 induction in the rat.
Paolini M; Pozzetti L; Perocco P; Mazzullo M; Cantelli-Forti G
Cancer Lett; 1999 Jan; 135(2):203-13. PubMed ID: 10096430
[TBL] [Abstract][Full Text] [Related]
9. Cytochrome P450 gene induction in rats ex vivo assessed by quantitative real-time reverse transcriptase-polymerase chain reaction (TaqMan).
Baldwin SJ; Bramhall JL; Ashby CA; Yue L; Murdock PR; Hood SR; Ayrton AD; Clarke SE
Drug Metab Dispos; 2006 Jun; 34(6):1063-9. PubMed ID: 16531474
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of 7-benzyloxy-4-trifluoromethylcoumarin, some other 7-hydroxy-4-trifluoromethylcoumarin derivatives and 7-benzyloxyquinoline as fluorescent substrates for rat hepatic cytochrome P450 enzymes.
Renwick AB; Lavignette G; Worboy PD; Williams B; Surry D; Lewis DF; Price RJ; Lake BG; Evans DC
Xenobiotica; 2001 Dec; 31(12):861-78. PubMed ID: 11780761
[TBL] [Abstract][Full Text] [Related]
11. Negative regulation by dexamethasone of fluvastatin-inducible CYP2B expression in primary cultures of rat hepatocytes: role of CYP3A.
Kocarek TA; Reddy AB
Biochem Pharmacol; 1998 May; 55(9):1435-43. PubMed ID: 10076536
[TBL] [Abstract][Full Text] [Related]
12. Strain differences in hepatic cytochrome P450 1A and 3A expression between Sprague-Dawley and Wistar rats.
Kishida T; Muto S; Hayashi M; Tsutsui M; Tanaka S; Murakami M; Kuroda J
J Toxicol Sci; 2008 Oct; 33(4):447-57. PubMed ID: 18827444
[TBL] [Abstract][Full Text] [Related]
13. Ethylmorphine N-demethylase activity as a marker for cytochrome P450 CYP3A activity in rat hepatic microsomes.
Amacher DE; Schomaker SJ
Toxicol Lett; 1998 Jan; 94(2):115-25. PubMed ID: 9574808
[TBL] [Abstract][Full Text] [Related]
14. Escherichia coli MTC, a human NADPH P450 reductase competent mutagenicity tester strain for the expression of human cytochrome P450 isoforms 1A1, 1A2, 2A6, 3A4, or 3A5: catalytic activities and mutagenicity studies.
Kranendonk M; Carreira F; Theisen P; Laires A; Fisher CW; Rueff J; Estabrook RW; Vermeulen NP
Mutat Res; 1999 Apr; 441(1):73-83. PubMed ID: 10224324
[TBL] [Abstract][Full Text] [Related]
15. Increased activity of CYP3A enzyme in primary cultures of rat hepatocytes treated with docetaxel: comparative evaluation with paclitaxel.
Nallani SC; Genter MB; Desai PB
Cancer Chemother Pharmacol; 2001 Aug; 48(2):115-22. PubMed ID: 11561777
[TBL] [Abstract][Full Text] [Related]
16. Induction of cytochrome P450 (CYP)1A1, CYP1A2, and CYP3A4 but not of CYP2C9, CYP2C19, multidrug resistance (MDR-1) and multidrug resistance associated protein (MRP-1) by prototypical inducers in human hepatocytes.
Runge D; Köhler C; Kostrubsky VE; Jäger D; Lehmann T; Runge DM; May U; Stolz DB; Strom SC; Fleig WE; Michalopoulos GK
Biochem Biophys Res Commun; 2000 Jun; 273(1):333-41. PubMed ID: 10873607
[TBL] [Abstract][Full Text] [Related]
17. Methodologies to study the induction of rat hepatic and intestinal cytochrome P450 3A at the mRNA, protein, and catalytic activity level.
Cotreau MM; von Moltke LL; Beinfeld MC; Greenblatt DJ
J Pharmacol Toxicol Methods; 2000; 43(1):41-54. PubMed ID: 11091129
[TBL] [Abstract][Full Text] [Related]
18. Involvement of CYP3A1, 2B1, and 2E1 in C-8 hydroxylation and CYP 1A2 and flavin-containing monooxygenase in N-demethylation of caffeine; identified by using inducer treated rat liver microsomes that are characterized with testosterone metabolic patterns.
Chung WG; Roh HK; Kim HM; Cha YN
Chem Biol Interact; 1998 May; 113(1):1-14. PubMed ID: 9630843
[TBL] [Abstract][Full Text] [Related]
19. Effect of extracellular matrix on the expression of peroxisome proliferation associated genes in cultured rat hepatocytes.
Hong JT; Glauert HP
Toxicol In Vitro; 2000 Apr; 14(2):177-84. PubMed ID: 10793296
[TBL] [Abstract][Full Text] [Related]
20. Oltipraz-mediated changes in aflatoxin B(1) biotransformation in rat liver: implications for human chemointervention.
Buetler TM; Bammler TK; Hayes JD; Eaton DL
Cancer Res; 1996 May; 56(10):2306-13. PubMed ID: 8625305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
